Pharmacogenomics of maternal tobacco use: metabolic gene polymorphisms and risk of adverse pregnancy outcomes.
Aagaard-Tillery K, Spong CY, Thom E, Sibai B, Wendel G Jr, Wenstrom K, Samuels P, Simhan H, Sorokin Y, Miodovnik M, Meis P, O'Sullivan MJ, Conway D, Wapner RJ; Eunice Kennedy Shriver National Institute of Child Health, Human Development (NICHD) Maternal–Fetal Medicine Units Network (MFMU).
Aagaard-Tillery K, et al.
Obstet Gynecol. 2010 Mar;115(3):568-577. doi: 10.1097/AOG.0b013e3181d06faf.
Obstet Gynecol. 2010.
PMID: 20177288
Free PMC article.